Background Cystic fibrosis associated liver disease (CFLD) carries a significant disease
burden with no effective preventive therapies. According to the gut-liver axis hypothesis for …

Aim Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD).
In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease …

Cystic fibrosis (CF) is the most common fatal genetic disease in North America. While CF is
more common among Whites, it is increasingly being recognized in other races and …

Cystic fibrosis (CF; OMIM 219700) is a rare genetic disorder caused by a chloride channel
defect, resulting in lung disease, pancreas insufficiency and liver impairment. Altered L …

The inherited diseases causing conjugated hyperbilirubinemia are diverse, with variability in
clinical severity, histologic appearance, and time of onset. The liver biopsy appearances can …

Cystic fibrosis (CF) is a progressive multi-organ disease with significant morbidity placing
extensive demands on the healthcare system. Little is known about those individuals with …

Background Improved survival of children with CF has increased our need to understand the
relevance of cystic fibrosis-associated liver disease (CFLD). We assessed the impact of liver …

Cystic fibrosis (CF) is an inherited autosomal recessive disorder. Despite optimized therapy,
the majority of affected individuals ultimately die of respiratory failure. As patients with CF …

Uncontrolled inflammation is a salient factor in multiple chronic inflammatory diseases and
cancers. In this review, we provided an in-depth analysis of the relationships and distinctions …

The purpose of this work is the evaluation of the nutritional status of patients with cystic
fibrosis (CF), based on the level of vitamin C in urine and vitamins A and E in serum, using …